Skip to Main Content

Paper Details

Assessment of predicted enzymatic activity of α-N-acetylglucosaminidase variants of unknown significance for CAGI 2016.
Hum Mutat
10
2019
CAGI, CAGI 2016, Deficiencies in NAGLU, MPS type IIIB, N-acetylglucosaminidase, NAGLU, Sanfilippo syndrome type B, VUS, lysosomal hydrolase -N-acetylglucosaminidase, lysosomal storage disorder, participants, rare
Author NameAffiliation
Wyatt T ClarkBioMarin Pharmaceutical
Constantina BakolitsaUniversity of California berkeley
Yana BrombergRutgers University
Rita CasadioDepartment of Pharmacy and Biotechnology, University of Bologna
Roland L DunbrackInstitute for Cancer Research, Fox Chase Cancer Center
David JonesUniversity College London
Olivier LichtargeBaylor College of Medicine
Olivier LichtargeBaylor College of Medicine
Olivier LichtargeBaylor College of Medicine
Olivier LichtargeComputational and Integrative Biomedical Research Center, Baylor College of Medicine
Pier Luigi MartelliInstitute of Biomedicine and Translational Medicine, University of Tartu
Sean D MooneyBuck Institute for Research on Aging
Sean D MooneyBuck Institute for Research on Aging
Predrag RadivojacIndiana University
Predrag RadivojacIndiana University
Castrense SavojardoDepartment of Pharmacy and Biotechnology, University of Bologna
Yaoqi ZhouCenter for Computational Biology and Bioinformatics, Indiana University School of Medicine
Vikas PejaverIndiana University
Vikas PejaverIndiana University
John MoultInstitute for Bioscience and Biotechnology Research, University of Maryland
John MoultUniversity of Maryland, College Park
Steven E BrennerUniversity of California berkeley
Steven E BrennerUniversity of California berkeley
  • 1 - 23

Datasets

Release 1.2